These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model. Datta K, Lauritzen MH, Merchant M, Jang T, Liu SC, Hurd R, Recht L, Spielman DM. PLoS One; 2019; 14(12):e0225313. PubMed ID: 31830049 [Abstract] [Full Text] [Related]
3. Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Park JM, Recht LD, Josan S, Merchant M, Jang T, Yen YF, Hurd RE, Spielman DM, Mayer D. Neuro Oncol; 2013 Apr; 15(4):433-41. PubMed ID: 23328814 [Abstract] [Full Text] [Related]
7. Simultaneous fMRI and metabolic MRS of hyperpolarized [1-13C]pyruvate during nicotine stimulus in rat. Hyppönen VA, Rosa J, Kettunen MI. NMR Biomed; 2024 May; 37(5):e5108. PubMed ID: 38273732 [Abstract] [Full Text] [Related]
13. Regional quantification of cardiac metabolism with hyperpolarized [1-13C]-pyruvate CMR evaluated in an oral glucose challenge. Larson PEZ, Tang S, Liu X, Sinha A, Dwork N, Sivalokanathan S, Liu J, Bok R, Ordovas KG, Slater J, Gordon JW, Abraham MR. J Cardiovasc Magn Reson; 2023 Dec 14; 25(1):77. PubMed ID: 38093285 [Abstract] [Full Text] [Related]
14. Assessment of higher-order singular value decomposition denoising methods on dynamic hyperpolarized [1-13C]pyruvate MRI data from patients with glioma. Vaziri S, Autry AW, Lafontaine M, Kim Y, Gordon JW, Chen HY, Hu JY, Lupo JM, Chang SM, Clarke JL, Villanueva-Meyer JE, Bush NAO, Xu D, Larson PEZ, Vigneron DB, Li Y. Neuroimage Clin; 2022 Dec 14; 36():103155. PubMed ID: 36007439 [Abstract] [Full Text] [Related]
17. Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. Golman K, Zandt RI, Lerche M, Pehrson R, Ardenkjaer-Larsen JH. Cancer Res; 2006 Nov 15; 66(22):10855-60. PubMed ID: 17108122 [Abstract] [Full Text] [Related]